ライフサイエンスコーパス: partum

1 infant mortality (deaths until 90 days post partum).

2 o delivery and followed for four months post-partum.

3 time of onset throughout pregnancy and post partum.

4 g pregnancy or in the first four months post-partum.

5 nancy but significantly decreased 1 day post-partum.

6 he nascent epithelium at the forth week post-partum.

7 e were restored to normal levels 7 days post-partum.

8 ion through planned weaning by 6 months post partum.

9 aire at the last 4 pregnancy visits and post partum.

10 re returned to standard laboratory chow post partum.

11 groups of women at 6 weeks and 6 months post partum.

12 , every month from enrolment to 90 days post partum.

13 d economic indicators in the first year post partum.

14 ho received Tdap vaccine within 14 days post partum.

15 stnatal day 1 and resolution by 2 weeks post partum.

16 rotocol) from enrollment until 24 hours post partum.

17 er and baby, but it resolves completely post partum.

18 diabetes was excluded at 4 to 16 weeks post partum.

19 the maternal circulation for many years post partum.

20 enrolled a mean (+/-SD) of 16+/-2 days post partum.

21 ng women were enrolled 5.6+/-0.8 months post partum.

22 malities and died between 7 and 21 days post-partum.

23 period; 797 of the women were pregnant/post partum.

24 e associated with long-term morbidities post partum.

25 catchment area for follow-up of 28 days post-partum.

26 s 11 [7%] of 168 pairs; 10.3, 5.4-19.7) post partum.

27 missions for the child within 24 months post-partum.

28 nce of proposed services up to 6 weeks' post partum.

29 m, and for about 75% during months 4-21 post partum.

30 at baseline and at 2, 6, and 12 months post-partum.

31 of 50 ng/mL, both during pregnancy and post partum.

32 than spermidine, except for the 5th day post-partum.

33 owed 100 women with PPCM through 1 year post-partum.

34 evels up to 4.41 mumol/l on the 3rd day post-partum.

35 he 1st, 2nd, 3rd, 4th, 5th and 15th day post-partum.

36 at presentation and at 6 and 12 months post-partum.

37 at week 1 (n = 10) and 4 weeks (n = 9) post-partum.

38 and are expected to resolve or improve post partum.

39 omen and women who were not pregnant or post partum.

40 e nipple can be symptomatic and persist post partum.

41 th age in hours over the first few days post partum.

42 -19, 173.7 %) fetal and neonatal (1 day post partum, 161 %) TG+ compared with transgenic negative (TG

43 At 6 weeks' post partum, 174 participants in the intervention group (81%)

44 More episodes began post partum (40.1%), followed by during pregnancy (33.4%) and

45 repregnancy weight, 7.8 kg; mean months post partum, 5.2 months) randomized to the intervention group

46 ) and late (32-36 weeks) pregnancy, and post-partum (6-10 weeks after delivery).

47 tiretroviral treatment 6 months or more post partum (7.8% and 12.0%, respectively; P=0.39).

48 By 32 weeks post partum, 96% of women in the intervention groups and 88%

49 cause neonatal mortality within 28 days post-partum among babies who survived the first 24 h of life.

50 years in women who were not pregnant or post partum and 11.8 (8.4-15.3) per 1000 person-years in preg

51 22.4) in women who were not pregnant or post partum and 8.2 (5.7-11.8) in pregnant or post-partum wom

52 cause neonatal mortality within 28 days post-partum and all-cause neonatal mortality within 28 days p

53 Plasma samples were obtained 10 days post partum and analyzed for resistance mutations.

54 mal elastic fibers in the uterine tract post partum and develop pelvic organ prolapse, enlarged airsp

55 yaloid vessels are persistent at 8 days post-partum and the retinal vasculature overgrows.

56 included retention in care at 6 weeks' post partum and uptake of PMTCT services, measured by attenda

57 tal development (between days 23 and 30 post partum) and independently of the presence of testosteron

58 ith a second pregnancy within 24 months post-partum, and emergency attendances and hospital admission

59 regnancy, for 66% in the first 3 months post partum, and for about 75% during months 4-21 post partum

60 gimen of zidovudine given ante partum, intra partum, and to the newborn.

61 Interventions, including peri-partum antibiotics and Cesarean sections, may have unint

62 persistent in the maternal circulation post-partum are associated with protection against invasive b

63 etained in care at 6 weeks and 12 weeks post partum (assessed by generalised linear mixed effects mod

64 to oxytocin when used to stop excessive post-partum bleeding suspected to be due to uterine atony in

65 ts were made during pregnancy and early post partum by peer counsellors recruited from the same commu

66 were offered screening at 4 to 6 weeks post partum by telephone.

67 Three had myocarditis, 4 had post-partum cardiomyopathy (PPCM), and 1 had idiopathic cardi

68 t of self-test distribution: two in the post-partum care group and two female sex workers.

69 enrolled (61 in antenatal care, 117 in post-partum care, and 102 female sex workers); follow-up inte

70 ts in antenatal care, two (2%) of 91 in post-partum care, and 41 (14%) of 298 from female sex workers

71 in antenatal care, 62 (68%) of 91 from post-partum care, and 53 (83%) of 64 female sex workers.

72 s in antenatal care, 91 (86%) of 106 in post-partum care, and 64 (75%) of 85 female sex workers.

73 regnancy, antenatal, labour, birth, and post-partum care, and family planning.

74 of weather metrics, to assess pre- and post-partum climatic influences on survival on herds in popul

75 a: a health facility with antenatal and post-partum clinics and a drop-in centre for female sex worke

76 B-myb expression decreases at day 18 post partum, coincident with the initial appearance of late p

77 had a relapse within the first 6 months post partum compared with 29 women (24.2%) who intended to br

78 tly reduced depression levels 12 months post partum compared with a control.

79 reased stroke risk during pregnancy and post partum compared with their nonpregnant contemporaries.

80 s (</=6 months post partum) with severe post-partum depression (Hamilton Rating Scale for Depression

81 Post-partum depression is a serious mood disorder in women th

82 igation of brexanolone in patients with post-partum depression is in progress.

83 INTERPRETATION: In women with severe post-partum depression, infusion of brexanolone resulted in a

84 (GABAA) receptors, for the treatment of post-partum depression.

85 elopment of therapies for patients with post-partum depression.

86 nd caesarean deliveries, from triage to post-partum discharge) and breast cancer care (diagnosis, che

87 scription ceases in the ovary by 3 days post partum (dpp), but continues in the testis through adulth

88 ight in meters] of 25 to 30) at 4 weeks post partum either to restrict their energy intake by 500 kca

89 e is more common in women than men, and post partum exacerbation of thyroiditis is common.

90 At 3 months post partum, exclusive breastfeeding was practised by 67% of

91 port of persistent Y chromosomal DNA in post-partum female dogs and these results suggest that fetal

92 table in blood samples obtained 10 days post partum from 32 percent of the women who had received int

93 In this pilot study on umbilical cords post partum from healthy non-obese (BMI = 19-25; n = 7) and o

94 2% of 244 women followed to four months post-partum had attended an HIV clinic and been assessed for

95 aemorrhage (1.49, 1.01-2.20; I(2)=37%), post-partum haemorrhage (1.29, 1.13-1.49; I(2)=41%), hyperten

96 ibiotics to reduce maternal deaths from post-partum haemorrhage and sepsis could be a highly effectiv

97 es from published work of occurrence of post-partum haemorrhage and sepsis, case fatality, and the ef

98 (10%) women were diagnosed with primary post-partum haemorrhage and were randomly assigned to receive

99 809 (3%) women were diagnosed with post-partum haemorrhage and were randomly assigned to receive

100 o intravenous oxytocin for treatment of post-partum haemorrhage in women not exposed to oxytocin duri

101 o intravenous oxytocin for treatment of post-partum haemorrhage in women receiving prophylactic oxyto

102 y events leading to maternal death from post-partum haemorrhage or sepsis after delivery.

103 mated that of 2860 maternal deaths from post-partum haemorrhage or sepsis per year in Malawi, interve

104 could reduce maternal mortality due to post-partum haemorrhage or sepsis.

105 Deaths from post-partum haemorrhage peaked 2-3 h after childbirth.

106 women in the placebo group with severe post-partum haemorrhage than those in the cholecalciferol gro

107 in acute severe bleeding (traumatic and post-partum haemorrhage).

108 Most maternal deaths were caused by ante-partum haemorrhage, except in Ragh, where a greater prop

109 , the standard of care for treatment of post-partum haemorrhage, is not available in all settings bec

110 ytocin, the gold-standard treatment for post-partum haemorrhage, needs refrigeration, intravenous inf

111 educe death from bleeding in trauma and post-partum haemorrhage.

112 le first-line treatment alternative for post-partum haemorrhage.

113 Retained placenta is associated with post-partum haemorrhage.

114 l and caesarean births, infections, and post-partum haemorrhage.

115 r and delivery, and are more at risk of post-partum haemorrhage.

116 ew of its relevance in time-to-death in post-partum haemorrhage.

117 creasingly used ad hoc for treatment of post-partum haemorrhage; however, evidence is insufficient to

118 Maternal depression (antepartum or post partum) has been linked to negative health-related behav

119 pregnancy, neonatal thyrotoxicosis, and post-partum hyperthyroidism.

120 The lesions persisted post partum in 22 patients (88%).

121 esistance mutations at day 10 or week 6 post partum in each arm was compared with that of a historica

122 0.5 kg per week between 4 and 14 weeks post partum in overweight women who are exclusively breast-fe

123 to June 30, 2012, with 1 year follow-up post partum in the nationwide German MS and pregnancy registr

124 ional studies are needed to examine the post-partum increase in viremia.

125 At 2 weeks post partum, initial intervention materials appropriate to th

126 three-part regimen of zidovudine given ante partum, intra partum, and to the newborn.

127 At 1 day post-partum, lactationally active, distended lobuloalveoli fa

128 henotypes of EL mice are dependent upon post-partum maternal care which if systematically enhanced ca

129 mother-infant dyads within the first 15 post-partum months utilizing peptide microarray.

130 als of litters issued from IAA-positive ante partum mothers develop E-IAA with a significantly higher

131 At 6 months post-partum, mothers were asked if they had experienced sympt

132 and repeated during lactation 12 weeks post-partum (n14) and twice in NPNL women (n23 and n10, respe

133 ospholipids) and secretion from the late pre-partum/non-lactating period through the end of subsequen

134 women died between 2 weeks and 48 weeks post partum (one in maternal-antiretroviral group, two in inf

135 ed as prominent symptom dimensions with post-partum onset and were notably severe.

136 of abbreviated regimens that are begun intra partum or in the first 48 hours of life.

137 l complications occurring up to 6 weeks post partum or until hospital discharge, whichever was later.

138 0.001), and presentation after 6 weeks post-partum (p = 0.02) were associated with a lower LVEF at 1

139 ediately after birth (P0) or at 10 days post partum (P10) to determine whether neural responses follo

140 e neurological symptoms in pregnant and post-partum patients is likely to improve as we learn more ab

141 rthyroidism in pregnancy and during the post-partum period are special circumstances that need carefu

142 iated with HIV during pregnancy and the post-partum period in sub-Saharan Africa.

143 The post-partum period represents an important opportunity to opt

144 tfeeding and history of low mood in the post-partum period.

145 developed in the intrapartum and early post-partum period.

146 attention throughout pregnancy and the post-partum period.

147 e mental disorders in pregnancy and the post-partum period.

148 ed, 235 of them during pregnancy or the post-partum period.

149 l depression (ie, during antepartum and post-partum periods) among women residing in low-income and m

150 s endogenously during pre-menstrual and post-partum periods, when decreased response to BDZ has been

151 vention should include preconception or post-partum periods.

152 ymptom onset within pregnancy and three post-partum periods.

153 Pregnant or post-partum person-years were calculated for HIV-infected and

154 e, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7).

155 ne day post-partum (PP1) and iv) 7 days post-partum (PP7).

156 ilable during pregnancy and immediately post partum, pregnancy-related loss of maternal renal functio

157 By 5 days post-partum, prominent expression became restricted to muscle

158 those with the onset of new episodes of post-partum psychosis.

159 on was significantly increased by day 1 post partum, reaching levels greater than those normally achi

160 f HAART from pregnancy through 6 months post partum resulted in high rates of virologic suppression,

161 e in prepartum or postpartum women, although partum status did have a significant affect on sulfadoxi

162 HIV status and partum status did not show any significant influence on

163 Post-partum surgical complications and prolonged hospital sta

164 wal paradigm, designed to mimic PMS and post-partum syndrome in a rat model.

165 erval, 4.1 to 8.9 percent); when begun intra partum, the rate was 10.0 percent (3.3 to 21.8 percent);

166 sion of milk proteins, and by two weeks post-partum their pups are smaller in size.

167 d from the mothers weekly until 4 weeks post partum then monthly.

168 however, whether treatment can prevent post-partum thyroiditis in women who are or have been antibod

169 Post-partum thyroiditis is substantially more frequent in wom

170 Post-partum thyroiditis occurs in 5-10% of women, and many of

171 ective of this study was to monitor the post-partum variation of polyamine content, in ovine and capr

172 rnal mood between delivery and 6 months post-partum was associated with an increased risk of infantil

173 ood glucose, and increased attention to post-partum weight management.

174 ring during pregnancy and up to 42 days post partum were defined as pregnancy related.

175 HIV status who died during pregnancy or post partum were HIV infected.

176 an LVEDD >/=6.0 cm recovered by 1 year post-partum, whereas 91% with both a baseline LVEF >/=0.30 an

177 referred female inpatients (</=6 months post partum) with severe post-partum depression (Hamilton Rat

178 data prospectively for all pregnant or post-partum women admitted to the obstetric department.

179 rates were compared between pregnant or post-partum women and women who were not pregnant or post par

180 at roughly 24% of deaths in pregnant or post-partum women are attributable to HIV in sub-Saharan Afri

181 e neurological symptoms in pregnant and post-partum women could be caused by exacerbation of a pre-ex

182 HIV-infected pregnant or post-partum women had around eight times higher mortality tha

183 artum and 8.2 (5.7-11.8) in pregnant or post-partum women.

184 3) per 1000 person-years in pregnant or post-partum women.

185 o the needs of HIV-infected pregnant or post-partum women.